Medical technology company C-Rad and SeeTreat have entered into a partnership to develop interconnected workflows for personalized radiation therapy.
In 2027, C-Rad’s Catalyst+ HD platform for patient positioning and motion monitoring will be combined with SeeTreat’s ART.1, which provides automated decision support for adaptive treatment planning. SeeTreat will be the first partner in C-Rad’s open workflow platform. No financial details.
